sofosbuvir 400 MG Oral Tablet [Sovaldi]

RxCUI: 1484922
RxNorm name: sofosbuvir 400 MG Oral Tablet [Sovaldi]
Display name: sofosbuvir 400 MG Oral Tablet [Sovaldi]
Full name: sofosbuvir 400 MG Oral Tablet [Sovaldi]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sovaldi	SOFOSBUVIR	Gilead Sciences, Inc.	80beab2c-396e-4a37-a4dc-40fdb62859cf	2024-12-26	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1484922

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
80beab2c-396e-4a37-a4dc-40fdb62859cf	Sovaldi 400 MG Oral Tablet [PSN] · sofosbuvir 400 MG Oral Tablet [Sovaldi] [SBD] · Sovaldi 400 MG Oral Tablet [SY]	3	16	These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. SOVALDI ® (sofosbuvir) tablets, for oral use SOVALDI ® (sofosbuvir) oral pellets Initial U.S. Approval: 2013	20241226
b66d2de5-8550-4015-9c2c-d7a9150926b4	Sovaldi 400 MG Oral Tablet [PSN] · sofosbuvir 400 MG Oral Tablet [Sovaldi] [SBD] · Sovaldi 400 MG Oral Tablet [SY]	3	9	These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. GILEAD ACCESS PROGRAM SOVALDI™ (sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013	20201220